Osimertinib vs Yttrium Y 90 Ibritumomab Tiuxetan
Osimertinib vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview
This comparison examines the pharmacological differences between Osimertinib and Yttrium Y 90 Ibritumomab Tiuxetan.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2.
Molecular Weight: Osimertinib β 499.6050 g/mol.
Type: Osimertinib β Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan β Antibody.